Cargando…
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
BACKGROUND: TAS0313 is a multi-epitope long peptide vaccine targeting several cancer-associated antigens highly expressed in multiple cancer types, including glioblastoma (GBM). This cohort of a Phase 2 part evaluated the efficacy and safety of TAS0313 in patients with GBM. METHODS: TAS0313 (27 mg)...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519730/ https://www.ncbi.nlm.nih.gov/pubmed/35377001 http://dx.doi.org/10.1007/s00262-022-03184-7 |